<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02702297</url>
  </required_header>
  <id_info>
    <org_study_id>MuMFI-PPROM</org_study_id>
    <nct_id>NCT02702297</nct_id>
  </id_info>
  <brief_title>Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes</brief_title>
  <acronym>MuMFI-PPROM</acronym>
  <official_title>Multimodales Monitoring Des Fetalen Inflammationsrisikos Bei frühem Vorzeitigen Blasensprung (PPROM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Martin-Luther-Universität Halle-Wittenberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jena University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Elisabeth Hospital Halle</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Martin-Luther-Universität Halle-Wittenberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine whether the value of vaginal fluid cytokine levels as
      well as computerized fetal ECG analysis are suitable clinical parameters to detect an
      imminent intra-amniotic inflammation with a high risk of fetal inflammatory response syndrome
      (FIRS) or a neonatal early onset sepsis (EOS) and whether these parameters can be determined
      on a daily basis in the clinical monitoring of pregnancies complicated by PPROM.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preterm premature rupture of membranes (PPROM) is one of the leading causes for preterm birth
      and adverse neonatal outcome. Between 24 0/7 and 34 0/7 weeks of gestation the prolongation
      of pregnancy is the recommended course of action to reduce the risks of prematurity in most
      countries. An intra-amniotic infection resulting in fetal inflammatory response syndrome
      (FIRS) or early onset neonatal sepsis (EOS) is often associated with high morbidity and
      mortality.

      Standard monitoring includes the maternal response to inflammation (i.e. maternal serum
      parameters) as well as fetal signs of acute FIRS (i.e. fetal tachycardia, high cytokine level
      in amniotic fluid obtained by amniocentesis). Changes of fetal ECG-parameters are also a sign
      of an acute FIRS.

      Currently, there is no adequate parameter for the surveillance of a possible ongoing
      intra-amniotic infection. Other studies have reported a correlation between vaginal fluid
      interleukine 6 (IL6) collected noninvasively and the risk of FIRS and EOS. Information
      obtained by computerized fetal ECG analysis might be suitable to detect early signs of fetal
      infection before the manifestation of FIRS.

      With the implementation of a vaginal fluid collector it is possible to detect the vaginal
      fluid cytokine in clinical everyday routine. With the improvement of fetal ECG monitoring it
      is possible to record the fetal ECG daily. This study examines the correlation between these
      new parameters and the onset of fetal infection before the manifestation of a severe systemic
      fetal inflammation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 7, 2016</start_date>
  <completion_date type="Actual">November 10, 2018</completion_date>
  <primary_completion_date type="Actual">February 28, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Odds ratio for severe fetal/early onset neonatal Infection</measure>
    <time_frame>postpartum one point assessment/ first three days post partum</time_frame>
    <description>combined outcome - rate of: early onset neonatal sepsis, elevated IL6 concentration in cord blood sample, histological signs of funisitis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>combined neonatal adverse outcome</measure>
    <time_frame>28 days</time_frame>
    <description>rate of severe intraventricular hemorrhage, necrotizing enterocolitis, late onset sepsis, white matter damage within the first 28 days of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>late onset neonatal sepsis</measure>
    <time_frame>28 days</time_frame>
    <description>clinical Sepsis after first 72h of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe neonatal cerebral hemorrhage</measure>
    <time_frame>28 days</time_frame>
    <description>IVH II+IV°</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>necrotizing enterocolitis</measure>
    <time_frame>28 days</time_frame>
    <description>NEC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>umbilical cord blood IL 6 concentration</measure>
    <time_frame>first day after delivery</time_frame>
    <description>IL-6-concentration in cord blood sample after delivery or in fetal Serum during first hour of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neonatal early onset sepsis</measure>
    <time_frame>3 days</time_frame>
    <description>clinical Sepsis during first 72h of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>histological funisitis</measure>
    <time_frame>first day after delivery</time_frame>
    <description>redline maternal stage &gt;1, fetal stage &gt;0</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">57</enrollment>
  <condition>Preterm Premature Rupture of Membranes</condition>
  <condition>Fetal Inflammatory Response Syndrome</condition>
  <condition>Early Onset Neonatal Sepsis</condition>
  <condition>Infection of Amniotic Cavity</condition>
  <arm_group>
    <arm_group_label>Single arm</arm_group_label>
    <description>daily multimodal monitoring during pregnancy after PPROM, Analysis of neonatal routine parameters and histologic examination of placenta</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>single arm</intervention_name>
    <description>Daily monitoring of vaginal fluid IL6 and fetal ECG. Daily maternal monitoring and delivery according to standard operating procedure. Post partum diagnosis of FIRS or EOS by analysing of fetal cord blood IL6 and clinical signs of sepsis. Diagnosis of histologic amniotic infection by histological analysis.</description>
    <arm_group_label>Single arm</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Vaginal Fluid
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women with PPROM-complicated pregnancies who referre to one of the participating tertiary
        referreal care centers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of preterm rupture of the fetal membranes

          -  Pregnancy between 24 0/7 and 34 0/7 weeks of gestation

          -  Ability to give informed consent in german or english

        Exclusion Criteria:

          -  Sign of acute amniotic infection syndrome

          -  independent indication for urgent delivery

          -  Active labor

          -  Missing informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregor Seliger, Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternity Clinic/Perinatal Treatment Center, Halle university hospital, Martin-Luther-Universität Halle-Wittenberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Bergner</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternity Clinic/Perinatal Treatment Center, Halle university hospital, Martin-Luther-Universität Halle-Wittenberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Uwe Schneider, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternity Clinic; Jena University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Tchirikov, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Maternity Clinic/Perinatal Treatment Center, Halle university hospital, Martin-Luther-Universität Halle-Wittenberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frank Bernhard Kraus, PD; PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Laboratory Medicine; Halle university hospital, Martin-Luther-Universität Halle-Wittenberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roland Haase, PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatrics; Halle university hospital, Martin-Luther-Universität Halle-Wittenberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Holger Stepan, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternity clinic, University of Leipzig</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maternity Clinic/Perinatal Treatment Center, university hospital, Martin-Luther-Universität Halle-Wittenberg</name>
      <address>
        <city>Halle (Saale)</city>
        <state>Sachsen-Anhalt</state>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elisabeth Hospital Halle</name>
      <address>
        <city>Halle</city>
        <state>Sachsen-Anhalt</state>
        <zip>06110</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maternity clinic, University of Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maternity Clinic, Jena University Hospital</name>
      <address>
        <city>Jena</city>
        <state>Thüringen</state>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>February 22, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2016</study_first_posted>
  <last_update_submitted>November 12, 2018</last_update_submitted>
  <last_update_submitted_qc>November 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Martin-Luther-Universität Halle-Wittenberg</investigator_affiliation>
    <investigator_full_name>Gregor Seliger</investigator_full_name>
    <investigator_title>Dr. med.; chief resident</investigator_title>
  </responsible_party>
  <keyword>Preterm premature rupture of the membranes</keyword>
  <keyword>PPROM</keyword>
  <keyword>PROM</keyword>
  <keyword>fetal membranes</keyword>
  <keyword>premature rupture</keyword>
  <keyword>neonatal early onset sepsis</keyword>
  <keyword>amniotic fluid</keyword>
  <keyword>amniotic infection</keyword>
  <keyword>fetal inflammatory response syndrome</keyword>
  <keyword>adverse neonatal outcome</keyword>
  <keyword>FIRS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neonatal Sepsis</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

